The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

Cibc World Markets Corp acquired a new stake in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) in the ...

Bluebird said late Friday that Ayrmid made an unsolicited offer to buy the company in a cash-and-stock transaction with an upfront cash payment of $4.50 per share and a one-time contingent value right ...

Gene therapy maker bluebird bio said on Friday it had received a non-binding offer from peer Ayrmid for up to $110.5 million, sending its shares up 9.8% at $4.40 in extended trading.

Frederick L. Locke, MD, discussed cema-cel's safety, efficacy, and potential for treating large B-cell lymphoma in earlier ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Discover a recent first-in-human gene therapy trial that has shown promising results in improving glucose homeostasis.

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

CRISPR technology has revolutionised genetic engineering, offering unprecedented precision in DNA editing with vast implications for medicine, agriculture and conservation. Yet, its power demands ...